Ginkgo Investor Conference Presentation Deck slide image

Ginkgo Investor Conference Presentation Deck

Customers run their programs on Ginkgo's platform to drive business value Ginkgo partnered with Motif to develop more delicious and sustainable food. In just 1 year, 6 prototype strains were developed, and product samples were produced for benchmarking and early application testing. Improved variants were designed, built and validated over the next 9 months. The strain's performance exceeded Motif's specifications by >70%. Q1 IDENTIFY POTENTIAL PROTEINS Sequence Similarity Network Improvement Percent over Seed Protein Q2 SCREEN FOR BEST CANDIDATE PROTEIN Strain Q3 STRAIN ENGINEERING & PATHWAY BALANCING Percent Improvement over Unmodified Strains Strain 303 PROTEINS SOURCED Titer (g/L) Q4 ITERATIVE STRAIN CONSTRUCTION & TESTING 76 11 Strain motif 300% IMPROVEMENT OVER UNMODIFIED STRAINS FOODWORKS EXCERPT FROM MAY 2021 PIPE DECK 1 YEAR LATER PROTOTYPE STRAINS READY PROTOTYPE 13 Property of Ginkgo Bioworks J.P. MORGAN HEALTHCARE CONFERENCE 2022
View entire presentation